Eckert & Ziegler: Imminent start of the acceptance period for the mandatory takeover bid on IBt
Eckert & Ziegler Strahlen- und Medizintechnik AG / Offer
22.02.2010 09:50
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
Berlin, February 22, 2010 - The Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) announces that the acceptance period for the mandatory takeover bid in cash for IBt during which the IBt shareholders can sell their actions for 3,64 EUR will run from 23 February 2010 until 9 March 2010 (inclusive). The results of the takeover bid shall be published on 16 March 2010. The bid is jointly submitted with SMI Steglitz MedInvest UG (SMI). For more details, please consult the approved prospectus and the memorandum in response, once it is available at www.ezag.de
Contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112, E-Mail: karolin.riehle@ezag.de, www.ezag.de
22.02.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG Robert-Rössle-Str.10
13125 Berlin
Deutschland
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700, DE000A0L1L69
WKN: 565970, A0L1L6
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Düsseldorf, Hamburg
End of News DGAP News-Service